Literature DB >> 7815213

Local reactions to luteinizing hormone releasing hormone analog therapy.

G Tonini, S Marinoni, V Forleo, M Rustico.   

Abstract

Mesh：

Substances：

Year:  1995        PMID： 7815213     DOI： 10.1016/s0022-3476(95)70534-1

Source DB:  PubMed          Journal:  J Pediatr        ISSN： 0022-3476            Impact factor:   4.406


× No keyword cloud information.
  5 in total

1.  Significant adverse reactions to long-acting gonadotropin-releasing hormone agonists for the treatment of central precocious puberty and early onset puberty.

Authors:  Ji Woo Lee; Hyung Jin Kim; Yun Mee Choe; Hee Suk Kang; Soon Ki Kim; Yong Hoon Jun; Ji Eun Lee
Journal:  Ann Pediatr Endocrinol Metab       Date:  2014-09-30

2.  Imaging of recurrent intramuscular granulomatous masses induced by depot injection of leuprorelin.

Authors:  Emily N Vinson; Andresa Braga-Baiak; Leslie G Dodd; Salutario Martinez
Journal:  Skeletal Radiol       Date:  2011-08-23       Impact factor: 2.199

Review 3.  Central precocious puberty: current treatment options.

Authors:  Franco Antoniazzi; Giorgio Zamboni
Journal:  Paediatr Drugs       Date:  2004       Impact factor: 3.022

4.  Postinjection Muscle Fibrosis from Lupron.

Authors:  Erica Everest; Laurie A Tsilianidis; Nouhad Raissouni; Tracy Ballock; Terra Blatnik; Anzar Haider; Douglas G Rogers; B Michelle Schweiger
Journal:  Case Rep Pediatr       Date:  2015-05-25

Review 5.  Gonadotropin-releasing hormone analog therapies for children with central precocious puberty in the United States.

Authors:  Jadranka Popovic; Mitchell E Geffner; Alan D Rogol; Lawrence A Silverman; Paul B Kaplowitz; Nelly Mauras; Philip Zeitler; Erica A Eugster; Karen O Klein
Journal:  Front Pediatr       Date:  2022-10-04       Impact factor: 3.569
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.